It was reported that the patient with this cardiac resynchronization therapy defibrillator experienced a syncopal episode and was admitted to the intensive care unit.The syncopal episode resulted in a bruise on the patient's face.Technical services (ts) reviewed the available information and observed that the device was programmed to two tachycardia therapy zones.The patient had experienced ventricular tachycardia (vt) which met detection criteria for the first zone.This first zone did not have therapy delivery programmed on.It was reported that a change in rate zones would be discussed.The patient was also noted to have had some premature ventricular contractions (pvcs).The physician programmed ventricular rate regulation (vrr) off and brady pacing to vvir 70-100 and no further pvcs were noted.It was reported that the patient improved after the device reprogramming.The physician was concerned that the vrr programming was the cause of the patients pvcs; however, ts noted vrr had been pacing as designed and that the patient had a bundle branch block, so the pvcs could have been independent of the vrr pacing.The device remains in service.No additional adverse patient effects were reported.
|